Ernesto Munoz, MD
Internal Medicine · San Juan, PRNPI 1376104836
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $405 of the $450 with a category attached, or 89.9%. 9 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 33.7% of the total. Reporting peaked in 2022 at $190 and has fallen 82.7% since, to $33 in 2024. That places this record below the midpoint for internal medicine clinicians in PR, where the typical reported total is $603.
Across 17 payments — averaging $26.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$152
- Boehringer Ingelheim$65
- Chiesi USA, Inc.$46
- AstraZeneca$42
- Novo Nordisk$39
- Sanofi-aventis U.S. LLC$36
- plus $70 from 3 others
What the payments were for
- Food & beverage$40590%
- Gifts$4610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 2 | $152 |
| Boehringer Ingelheim | 3 | $65 |
| Chiesi USA, Inc. | 1 | $46 |
| AstraZeneca | 3 | $42 |
| Novo Nordisk | 2 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| PBG Puerto Rico LLC | 2 | $33 |
| Pfizer | 1 | $19 |
| Eisai Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$119
How this compares
$450 in reported general payments places this provider in the 40th percentile of 1,043 internal medicine providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 74 | $618 |
| Gabapentin | 40 | $455 |
| Nifedipine ErNifedipine | 20 | $431 |
| Losartan Potassium | 52 | $407 |
| Atorvastatin Calcium | 49 | $404 |
| Metoprolol Succinate | 32 | $384 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 19 | $325 |
| Hydralazine Hcl | 18 | $273 |
| Levothyroxine Sodium | 21 | $266 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 21 | $258 |
| Levofloxacin | 19 | $243 |
| Clonazepam | 30 | $233 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $210 |
| Simvastatin | 34 | $191 |
| Amlodipine Besylate | 37 | $188 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Juan
- Ricardo FernandezSan Juan$351K
- Norma SalgadoSan Juan$21K
- Victor Gordo GonzalezSan Juan$21K
- Roberto Calderon SantiagoSan Juan$20K
- Natalia Almodovar ArbeloSan Juan$9K
- Jeremy FelicianoSan Juan$8K
- Porfirio Diaz-RodriguezSan Juan$8K
- Pedro del Valle de TomasSan Juan$7K
- Rafael Figueroa NavarroSan Juan$6K
- Amilcar Torres FigueroaSan Juan$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.